Open-access Deep vein thrombosis after hair transplantation: a case report

Abstract

Although studies present robust evidence that longer duration surgical procedures are associated with increased risk of venous thromboembolism (VTE), to date no studies have specifically addressed this risk in the context of hair transplantation. The aim of this case report is to draw attention to the need for thrombotic risk stratification prior to this type of procedure, since it can identify high-risk patients, even for procedures considered low risk for VTE.

Keywords:
venous thrombosis; pulmonary embolism; patient safety; prophylaxis; alopecia; transplantation

Resumo

Embora estudos forneçam evidências robustas de que procedimentos cirúrgicos mais longos estão associados a risco aumentado de tromboembolismo venoso (TEV), nenhum estudo até o momento abordou especificamente esse risco no contexto do transplante capilar. O objetivo deste relato de caso é salientar a importância da estratificação de risco trombótico nesse tipo de procedimento, pois essa avaliação pode identificar pacientes de alto risco, mesmo em um procedimento considerado de baixo risco para TEV.

Palavras-chave:
trombose venosa; embolia pulmonar; segurança do paciente; profilaxia; alopecia; transplante

INTRODUCTION

Hair replacement surgery has evolved significantly since it was pioneered in the 1960s and 1970s. Continuous technical advances have improved safety, efficacy, and patient satisfaction.1 Nowadays, more than 700 thousand hair transplantation (HT) procedures are performed globally every year, using techniques such as follicular unit extraction and strip transplantation, which are widely used to treat androgenetic alopecia and scarring hair loss.2 These procedures can be used to restore hair to the scalp, eyebrows, beard, body hair, or areas of hair loss caused by scarring. While these methods are considered safe and minimally invasive, they are not risk free and can cause complications that range from mild and transitory effects to more serious intraoperative and postoperative events.2,3

Post-HT complications are rare when there is appropriate patient selection, strategic surgical planning, and careful procedure execution.3 Complications reported include postoperative edema, observed in up to 42.5% of patients, sterile folliculitis, donor scar expansion, and paresthesia.4 Less common, but clinically relevant complications, include cutaneous necrosis, MRSA infections, herpes-zoster, and arteriovenous fistulas.5 While studies have presented robust evidence that longer duration surgical procedures are associated with a greater risk of venous thromboembolism (VTE), to date, no studies have investigated this risk specifically in the context of HT, despite growing interest in the field of surgical safety.6

Venous thromboembolism includes both pulmonary embolism (PE) and deep venous thrombosis (DVT) and is a serious and potentially fatal condition, recognized as the third most common cause of acute cardiovascular syndrome worldwide.7

The chronic nature of VTE, compounded by recurrence and complications, means its effective management places a substantial financial burden on health care systems and patients. One study reported a crude cumulative risk of recurrent VTE of 25.2% in non-oncological patients.8 Complications related to VTE, such as post-thrombotic syndrome, which affects at least one third of patients with DVT, and chronic pulmonary hypertension, which occurs in 4 to 5% of patients after PE, contribute significantly to its morbidity and mortality.9 Additionally, the psychosocial impact of VTE can also be considerable, with high prevalence of anxiety, depression, and posttraumatic stress disorder.10

In this context, the primary objective of thromboprophylaxis (TP) is to prevent development of VTE, especially in high-risk patients, thereby reducing the morbidity and mortality associated with PE and mitigating its long-term sequelae, such as, for example, post-thrombotic syndrome. Thromboprophylaxis also contributes to reducing financial expenditure by health care systems (both public and private) and patients.11

Therefore, while there is scant data on VTE as a complication of HT, irrespective of the technique used, it is nonetheless necessary to identify high-risk patients and protect them with adequate TP.12

Case description

A 41-year-old male patient presented at a specialist HT clinic to seek treatment for alopecia for esthetic motives. He underwent HT with the follicular unit extraction technique, under local anesthesia and mild sedation for 10 hours, and remained in the same position for practically the entire procedure. He was discharged after 2 hours of postoperative rest. He stated that he had not undergone any type of VTE risk assessment and that no mechanical or pharmacological prophylactic measures had been adopted. Moreover, around 3 hours after starting the HT procedure, he had told the anesthetist that he was feeling minor discomfort in his left calf, but no measures were taken in response.

One week after the procedure, the patient presented at the emergency room with discomfort in the left calf and edema involving the ankle. After medical assessment, color Doppler ultrasonography of the lower limbs was ordered, showing the medial gastrocnemius veins were distended, with no blood flow, filled with hypoechogenic material, and had incompressible walls, suggesting DVT in the left lower limb (Figure 1). The emergency physician prescribed 15 mg oral rivaroxaban, twice a day, for 21 days, to be followed by 20 mg oral rivaroxaban once a day for 6 months. At outpatients follow-up, the only possible risk factors identified were a family history of DVT in a paternal uncle and overweight (body mass index: 26.4 kg/m2).

Figure 1
Color Doppler ultrasonography conducted in the emergency room, showing the medial gastrocnemius veins distended, with no blood flow, filled with hypoechogenic material, and with incompressible walls, suggesting a diagnosis of DVT. DVT = deep venous thrombosis.

Since this was a male patient with a DVT episode associated with a minor risk factor and at low risk of bleeding, after the first 6 months, the decision was taken in conjunction with the patient to extend anticoagulation indefinitely, with 10 mg rivaroxaban once a day. A color Doppler ultrasonography scan performed around 6 months after the event showed the gastrocnemius veins were patent and totally recanalized, with thickened walls and reflux (Figure 2).

Figure 2
Color Doppler ultrasonography performed about 6 months after the acute event showing the medial gastrocnemius veins patent and totally recanalized, with mild wall thickening and reflux.

This case report was approved by the Research Ethics Committee at the Faculdade de Medicina de Campos/Fundação Benedito Pereira Nunes, with CAAE submission certificate 95574926.7.0000.5244 and Opinion Number 8.319.565.

DISCUSSION

The association between VTE and HT is not yet well-established and there are very few studies describing this association in the medical literature. Bibliographic searches of four databases (PubMed, Embase, Cochrane Library, and SciELO) failed to identify studies of any type that directly assessed the incidence or risk of DVT, VTE, or PE specifically associated with HT procedures. However, a small number of related studies were found on SciELO and open-access sources. These included retrospective series assessing TP protocols in plastic surgery, with indirect mentions of HT in larger surgical populations.12-14

One prospective case series investigating fat-enriched hair follicle grafting in patients with alopecia documented routine use of mechanical DVT prevention (elastic compression stockings and pneumatic intermittent compression devices) observing a zero VTE rate.15,16

A Brazilian narrative review specifically addressed the lack of evidence on VTE in HT surgery, recommending individualized risk assessment despite the absence of reported cases.7

No case reports or clinical trials were found in any of the databases or manual searches that described DVT or PE after HT, indicating that such events are probably very rare or undernotified.

The Caprini score is a risk assessment model for predicting VTE that has been validated for several different surgical specialties,8,17 but not specifically for HT. Although the patient has a healthy lifestyle, objective application of this score would have flagged the patient as high risk with a total of at least 6 points (one point for age, two points for the duration of the procedure, and three points for the family history), indicating a need for pharmacoprophylaxis for at least 7 days to mitigate the risk of DVT.

According to Pannucci and Momeni,18 the risk of VTE can be assessed using paradigms for identification of patients, increase or reduction of risk during the preoperative, intraoperative, and postoperative periods. A careful and personalized approach to VTE can reduce, but never eliminate, the risk.

The case reported here highlights the relevance of individual assessment of VTE risk before esthetic procedures. While the thromboembolic risk of HT has not been clearly established, situations involving long duration surgery and immobility merit careful analysis of the individual and family characteristics of the patient. In this context, preventative strategies should be weighed up on a case-by-case basis, considering the variability of risk-benefit relationships at the individual level.

CONCLUSIONS

The scant data available relating VTE to HT procedures indicate that the prevalence of this complication is low. However, the significant morbidity and mortality associated with VTE suggest that thrombotic risk stratification before these procedures is important, since it can identify high-risk patients. Additional studies with appropriate methodology are needed to enable the correct strategy for this scenario to be robustly defined.

DATA AVAILABILITY

Data sharing is not applicable to this article as no new data were generated or analyzed.

How to cite:

Marques MA, Zulchner MA, Senfft ICN, Sanches SMV, Cerqueira MMBF, Ribeiro AJA Deep vein thrombosis after hair transplantation: a case report. J Vasc Bras. 2026;25:e20260068. https://doi.org/10.1590/1677-5449.202600682

Financial support:

None.

The study was carried out at the Faculdade de Medicina de Campos, Campos dos Goytacazes, RJ, Brazil.

Ethics committee approval:

This case report was approved by the Research Ethics Committee at the Faculdade de Medicina de Campos/Fundação Benedito Pereira Nunes, with CAAE submission certificate 95574926.7.0000.5244 and Opinion Number 8.319.565.

References

  • 1 Avram MR, Finney R, Rogers N. Hair transplantation controversies. Dermatol Surg. 2017;43(Suppl 2):S158-62. https://doi.org/10.1097/DSS.0000000000001316 PMid:29064980.
    » https://doi.org/10.1097/DSS.0000000000001316
  • 2 Khatib M, Skorochod R, Wolf Y. Complications following hair transplantation: a systematic literature review and meta-analysis. aesthetic plast surg. Aesthetic Plast Surg. 2025;49(23):6393-405. https://doi.org/10.1007/s00266-025-05125-y PMid:40913181.
    » https://doi.org/10.1007/s00266-025-05125-y
  • 3 Sand JP. Follicular unit transplantation. Facial Plast Surg Clin North Am. 2020;28(2):161-7. https://doi.org/10.1016/j.fsc.2020.01.005 PMid:32312502.
    » https://doi.org/10.1016/j.fsc.2020.01.005
  • 4 Nadimi S. Complications with hair transplantation. Facial Plast Surg Clin North Am. 2020;28(2):225-35. https://doi.org/10.1016/j.fsc.2020.01.003 PMid:32312509.
    » https://doi.org/10.1016/j.fsc.2020.01.003
  • 5 Loganathan E, Sarvajnamurthy S, Gorur D, Suresh DH, Siddaraju MN, Narasimhan RT. Complications of hair restoration surgery: a retrospective analysis. Int J Trichology. 2014;6(4):168-72. https://doi.org/10.4103/0974-7753.142861 PMid:25368473.
    » https://doi.org/10.4103/0974-7753.142861
  • 6 Perez-Meza D, Niedbalski R. Complications in hair restoration surgery. Oral Maxillofac Clin North Am. 2009;21(1):119-48. https://doi.org/10.1016/j.coms.2008.10.010
    » https://doi.org/10.1016/j.coms.2008.10.010
  • 7 Santos MB. Thrombosis prophylaxis in hair transplant surgery. Arq Catarin Med. 2023;52(3):54-62. https://doi.org/10.63845/kwve6t87
    » https://doi.org/10.63845/kwve6t87
  • 8 Albricker ACL, Freire CMV, Santos SN, et al. Diretriz conjunta sobre tromboembolismo venoso - 2022. Arq Bras Cardiol. 2022;118(4):797-857. https://doi.org/10.36660/abc.20220213 PMid:35508060.
    » https://doi.org/10.36660/abc.20220213
  • 9 Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost. 2014;112(2):255-63. https://doi.org/10.1160/TH13-09-0793 PMid:24695909.
    » https://doi.org/10.1160/TH13-09-0793
  • 10 Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756-64. https://doi.org/10.1160/TH07-03-0212 PMid:17938798.
    » https://doi.org/10.1160/TH07-03-0212
  • 11 Hunter R, Lewis S, Noble S, Rance J, Bennett PD. “Post-thrombotic panic syndrome”: a thematic analysis of the experience of venous thromboembolism. Br J Health Psychol. 2017;22(1):8-25. https://doi.org/10.1111/bjhp.12213 PMid:27611117.
    » https://doi.org/10.1111/bjhp.12213
  • 12 Sobreira ML, Marques MA, Paschôa AF, et al. Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular. J Vasc Bras. 2024;23:e20230107. https://doi.org/10.1590/1677-5449.202301071 PMid:39286300.
    » https://doi.org/10.1590/1677-5449.202301071
  • 13 Ceresetto JM, Giumelli C, Bottaro F, et al. Cómo generar recomendaciones de tromboprofilaxis venosa en instituciones de salud. Medicina (B Aires). 2024;84(Suppl 2):1-32. PMid:38823037.
  • 14 Paiva RA, Chadraoui J, Paiva R, Machado BB, Fischdick H, Pitanguy I. Venous thromboembolism prevention protocol in plastic surgery: results in 2759 patients at the Ivo Pitanguy Institute. Rev Bras Cir Plást. 2015;30(2):242-9. https://doi.org/10.5935/2177-1235.2015RBCP0144
    » https://doi.org/10.5935/2177-1235.2015RBCP0144
  • 15 Paiva RA, Chadraoui J, Machado BB, Amorim NFG, Fischdick H, Pitanguy I. Protocolo de prevenção de tromboembolismo venoso no Instituto Ivo Pitanguy: eficácia e segurança em 1.351 pacientes. Rev Bras Cir Plást. 2013;28(1):3-9. https://doi.org/10.1590/S1983-51752013000100003
    » https://doi.org/10.1590/S1983-51752013000100003
  • 16 Perez-Meza D, Ziering C, Sforza M, Krishnam G, Ball E, Danielo E. Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness. Stem Cells Cloning. 2017;10:1-10. https://doi.org/10.2147/SCCAA.S131431 PMid:28740409.
    » https://doi.org/10.2147/SCCAA.S131431
  • 17 Pannucci CJ, Barta RJ, Portschy PR, et al. Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg. 2012;130(2):343-53. https://doi.org/10.1097/PRS.0b013e3182589e49 PMid:22495215.
    » https://doi.org/10.1097/PRS.0b013e3182589e49
  • 18 Pannucci CJ, Momeni A. Venous thromboembolism in plastic surgery patients. Plast Reconstr Surg. 2026;157(3):421e-31e. https://doi.org/10.1097/PRS.0000000000012489 PMid:41739892.
    » https://doi.org/10.1097/PRS.0000000000012489

Conflicts of interest:

MAM receives speaker’s fees from pharmaceutical companies for lecturing on anticoagulants.

Correspondence

Correspondence Marcos Arêas Marques Universidade Federal do Estado do Rio de Janeiro – UNIRIO, Departamento de Cirurgia Geral e Especializada – DECIGE Rua Mariz e Barros, 775 - Bairro Maracanã CEP: 20270-004 – Rio de Janeiro (RJ), Brasil Tel.: +55 (21) 2264-4742 E-mail: mareasmarques@gmail.com

Editor-in-Chief responsible

Winston Bonetti Yoshida

Publication Dates

  • Publication in this collection
    26 Oct 2026
  • Date of issue
    2026

History

  • Received
    25 Apr 2026
  • Accepted
    18 Aug 2026
Creative Common - by 4.0
Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/), que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.
location_on
Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) Rua João Abbott, 109 - Petrópolis, CEP 90460-150 - Porto Alegre, RS, Fone: +55 (51) 99977.3480 (Veridiana Fraga) - Porto Alegre - RS - Brazil
E-mail: eic@jvascbras.org
rss_feed Stay informed of issues for this journal through your RSS reader
Go to top